Quantcast
Last updated on April 18, 2014 at 16:41 EDT

Latest Cystic fibrosis Stories

2012-01-05 14:00:00

SAN FRANCISCO, Jan. 5, 2012 /PRNewswire/ -- Celtaxsys, Inc. a privately held biotechnology company, announced today that it has acquired CTX-4430 (formerly EP-501), a clinical stage drug candidate that inhibits the pro-inflammatory enzyme Leukotriene A4 Hydrolase (LTA4H), from Estrellita Pharmaceuticals, Inc. In preclinical studies, CTX-4430 has demonstrated the ability to safely and effectively reduce the progression of chronic inflammation in several animal models. LTA4H is a...

2012-01-04 07:06:00

SAN DIEGO, Jan 4. 2012 /PRNewswire/ -- Youngevity® Essential Life Sciences (www.youngevity.com), a wholly-owned subsidiary of AL International (www.alintjcof.com) (JCOF-PK) and direct seller of lifestyle and nutritional products and gourmet healthy coffee, proudly announced that its founder, Dr. Joel D. Wallach, BS, DVM, ND is the 2011 recipient of the Klaus Schwarz Commemorative Medal. This prestigious award, sponsored by the International Association of...

2012-01-02 21:40:00

Scientific award recognizes discovery of Selenium-Cystic Fibrosis link San Diego, CA (PRWEB) January 02, 2012 WHAT: Dr. Joel Wallach will accept the Klaus Schwarz Medal and provide an overview of his work in mineral research. WHEN: January 5, 2012, 10 a.m. — 2 p.m. E.S.T.     WHERE:    Courtyard by Marriott, 3400 Creek Pointe Drive, East Point, GA 30344. Telephone: 404-344-4414. WHY: Cystic fibrosis (CF) is widely known as the second most...

2011-12-21 06:25:30

(Ivanhoe Newswire) — Adding inhaled powder mannitol to standard therapy for cystic fibrosis produced consistent lung function improvement for up to 52 weeks, according to this study. Mannitol treatment is not only efficient and safe, but it´s easy to administer as well. In the double-blind study, which was supported by Pharmaxis Limited, 318 patients were randomized to treatment with 400 mg bid inhaled mannitol or 50 mg bid inhaled mannitol (control group) for 26 weeks, followed...

2011-12-16 08:00:00

The Science Magazine EurekaMag.com publishes articles in all areas of biological science. The latest articles cover Chromatin which is is the combination of DNA and proteins that define the contents of a cell nucleus, IVIG which is a blood product containing the pooled IgG (immunoglobulin antibody G) extracted from blood plasma. The article on Mukoviszidose covers cystic fibrosis which is a genetic disease affecting the lungs, pancreas, liver and intestine. Mannheim, Germany (PRWEB) December...

2011-12-16 12:57:31

Adding inhaled dry powder mannitol to standard therapy for cystic fibrosis produced sustained improvement in lung function for up to 52 weeks, according to a new study. Along with the treatment's efficacy and good safety profile, the convenience and ease of administration of mannitol treatment may improve adherence with therapy in these patients. In the double-blind study, which was supported by Pharmaxis Limited, 318 patients were randomized to treatment with 400 mg bid inhaled mannitol...

2011-12-15 16:50:59

A new study has identified a gene mutation that researchers estimate dates back to 11,600 B.C., making it the second oldest human disease mutation yet discovered.   Researchers with the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute led the study and estimate that the mutation arose in the Middle East some 13,600 years ago. Only a mutation seen in cystic fibrosis that arose between 11,000 and 52,000...

2011-12-10 10:00:00

NASHVILLE, Tenn., Dec. 10, 2011 /PRNewswire/ -- Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children's Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K. To view the multimedia assets associated with this release, please click:...

2011-11-18 03:57:16

Interfering with the ability of biofilm-forming bacteria to sense starvation increases their susceptibility to antibiotics Many infections, even those caused by antibiotic-sensitive bacteria, resist treatment. This paradox has vexed physicians for decades, and makes some infections impossible to cure. A key cause of this resistance is that bacteria become starved for nutrients during infection. Starved bacteria resist killing by nearly every type of antibiotic, even ones they have never...

2011-11-14 15:17:38

Researchers at Harvard Medical School and Children's Hospital Boston have retraced the evolution of an unusual bacterial infection as it spread among cystic fibrosis patients by sequencing scores of samples collected during the outbreak, since contained. A significant achievement in genetic pathology, the work also suggests a new way to recognize adaptive mutations–to see evolution as it happens–and sheds new light on how our bodies resist infection. The results are to be...


Latest Cystic fibrosis Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »